Zobrazeno 1 - 2
of 2
pro vyhledávání: '"Amanda Kinderman"'
Autor:
Stephen E Gitelman, Brian N Bundy, Ele Ferrannini, Noha Lim, J Lori Blanchfield, Linda A DiMeglio, Eric I Felner, Jason L Gaglia, Peter A Gottlieb, S Alice Long, Andrea Mari, Raghavendra G Mirmira, Philip Raskin, Srinath Sanda, Eva Tsalikian, John M Wentworth, Steven M Willi, Jeffrey P Krischer, Jeffrey A Bluestone, Mayalin Barr, Jeanne Buchanan, Joanne Cabbage, Peter Coleman, Monica De La Vega, Carmella Evans-Molina, Christine Ferrara, Felicity Healy, Laurie Higgins, Megan Hildinger, Margaret Jenkins, Nora Kayton Bryant, Amanda Kinderman, Nisha Koshy, Brianne Kost, Suzanne Krishfield, Olena Kucheruk, Karen Lindsley, Manasa Mantravadi, Shelley Mesfin, Aaron Michels, Mary Ellen Migre, Pantea Minnock, Elham Mohammed-Nur, Jennifer Nelson, Ashvin Nursing, Ryan O'Donnell, Diana Olivos, Melissa Parker, Leanne Redl, Nicole Reed, Brittany Resnick, Peter Sayre, Elisavet Serti, Emily Sims, Karen Smith, Carol Soppe, Fiona Stuart, Sarah Szubowicz, Michel Tansey, Jennifer Terrell, Sarah Tersey, Christine Torok, Kelly Watson, Rebecca Wesch, Steven Willi, Stephanie Woerner
Publikováno v:
Lancet Diabetes Endocrinol
Type 1 diabetes results from autoimmune-mediated destruction of β cells. The tyrosine kinase inhibitor imatinib might affect relevant immunological and metabolic pathways, and preclinical studies show that it reverses and prevents diabetes. Our aim
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::bcc88b8333d4324e0044265eff7356ed
https://pubmed.ncbi.nlm.nih.gov/34214480
https://pubmed.ncbi.nlm.nih.gov/34214480
Autor:
Jay M. Sosenko, David Boulware, Dorothy J. Becker, Peter A. Gottlieb, Jane H. Buckner, Andrea K. Steck, Amanda Kinderman, Polly J. Bingley, Courtney Henderson, Emanuele Bosi, Susan Geyer
Publikováno v:
2017, ' Impact of age and antibody type on progression from single to multiple autoantibodies in type 1 diabetes relatives ', Journal of Clinical Endocrinology and Metabolism, vol. 102, no. 8, pp. 2881-2886 . https://doi.org/10.1210/jc.2017-00569
Context: Islet autoantibodies are markers of type 1 diabetes, and an increase in number of autoantibodies detected during the preclinical phase predicts progression to overt disease. Objective: To refine the effect of age in relation to islet antibod
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a382fd75e0291f1ad0f4fa9789fd150b
https://oup.silverchair-cdn.com/
https://oup.silverchair-cdn.com/
